Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 5700 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 3800 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 2850 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - nadroparin calcium, quantity: 1900 anti-xa iu - injection, solution - excipient ingredients: calcium hydroxide; water for injections - prophylaxis against deep vein thrombosis (dvt) associated with general or orthopaedic surgery. treatment of dvt. prevention of clotting during haemodialysis. prophylaxis of venous thromboembolism in high-risk medical patients who are immobilised due to acute illness or hospitalised in an intensive care unit.

Srbsko - srbčina - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

clinres farmacija d.o.o. beograd - надропарин-kalcijum - rastvor za injekciju u napunjenom injekcionom špricu - 2850i.j./0.3ml

Srbsko - srbčina - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

clinres farmacija d.o.o. beograd - надропарин-kalcijum - rastvor za injekciju u napunjenom injekcionom špricu - 5700i.j./0.6ml

Srbsko - srbčina - Агенција за лекове и медицинска средства Србије (Agencija za lekove i medicins)

predstavniŠtvo bgp products switzerland gmbh beograd-novi beograd - надропарин-kalcijum - rastvor za injekciju - 47500i.j./5ml

Rumunsko - rumunčina - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aspen notre dame de bondeville - franta - nadroparinum - sol. inj. - 9500 ui afxa/1 ml - antitrombotice grupul heparinei

Rumunsko - rumunčina - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aspen notre dame de bondeville - franta - nadroparinum - sol. inj. - 2850 ui afxa/0,3ml - antitrombotice grupul heparinei

Rumunsko - rumunčina - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

aspen notre dame de bondeville - franta - nadroparinum - sol. inj. - 5700 ui afxa/0,6ml - antitrombotice grupul heparinei